• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular Mechanism for Intracellular Signaling through CD36

Research Project

Project/Area Number 14570661
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionOSAKA UNIVERSITY

Principal Investigator

HIRAOKA Hisatoyo  Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 助手 (00273681)

Co-Investigator(Kenkyū-buntansha) ISHIGAMI Masato  Osaka University Hospital, Medical Staff, 医学部附属病院, 医員(臨床研究)
HIRANO Ken-ichi  Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 助手 (30332737)
YAMASHITA Shizuya  Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助教授 (60243242)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2003: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2002: ¥2,100,000 (Direct Cost: ¥2,100,000)
KeywordsNOS / Atherosclerosis / Nuclear receptors / CD36 / Genetic background / NO / 動脈硬化 / マクロファージ
Research Abstract

CD36, originally identified as glycoprotein IV on platelets, is an 88 kDa integral membrane protein that has multiple ligands and is expressed in the cardiovascular system (ie, blood vessel walls and the heart) as well as adipose tissues and skeletal muscles. Human genetic deficiency is relatively frequent in Asian and African populations. The investigation into the pathophysiology of this disorder has shown that CD36 may play an important role as a major scavenger receptor for oxidized low density lipoproteins and as a crucial transporter for long chain fatty acids. CD36 mediates intracellular signaling through some of important nuclear receptors such as NF-kB and PPARg and regulates inflammatory cytokines as well as inducible NOS. These results suggested that CD36 may play important roles in the pathogenesis of atherosclerosis.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Kuwasako T, et al.: "Lipoprotein Abnormalities in Human Genetic CD36 Deficiency Associated With Insulin Resistance and Abnormal Fatty Acid Metabolism"Diabetes Care. 26. 1647-1648 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirano K, et al.: "Pathophysiology of human genetic CD36 deficiency"Trends Cardiovasc Med. 13. 136-141 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sakai N, et al.: "Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA"J. Lipid Res. 44. 1256-1262 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyaoka K, et al.: "CD36 deficiency associated with insulin resistance"Lancet. 357. 686-687 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Janabi M.Y, et al.: "Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen"Biochem Biophys Res Commun. 283. 26-30 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Matsumoto K, et al.: "Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis"Arterioscler Thromb Vasc Biol. 20. 1027-1032 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Sakai N, et al.: "Measurement of fasting serum apolipoprotein B-48 levels in normolipidemic and hyperlipidemic subjects by ELISA."J Lipid Res.. 44. 1256-1262

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kuwasako T, et al.: "Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism."Diabetes Care.. 26. 1647-1648 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hirano K, et al.: "Pathophysiology of human genetic CD36 deficiency."Trends Cardiovas Med.. 13. 136-141 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyaoka K, et al.: "CD36 deficiency is associated with insulin resistance."Lancet.. 357. 686-687 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Janabi MY, et al.: "Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen."Biochem Biophys Res Commun.. 283. 26-30 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Matsumoto K, et al.: "Expression of Macrophage (Mf)Scavenger Receptor, CD36, in Cultured Human Aortic Smooth Muscle Cells, in Association with the Expression of Peroxisome Proliferator Activator Receptor-g -Gain of Mf-like Phenotype In Vitro and Its Implication in Atherogenesis-"Arterioscler Thromb Vasc Biol.. 20. 1027-1032 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Janabi MY, et al.: "Oxidized LDL-induced NF-kB activation and subsequent expression of proinflammatory gene expression in monocytes-derived macrophages from CD36 deficient patients."Arterioscler Thromb Vasc Biol.. 20. 1953-1960 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kuwasako T, et al.: "Lipoprotein abnormalities in human genetic CD36 deficiency"Diabetes Care. 26. 1647-1648 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hirano K, et al.: "Pathophysiology of human genetic CD36 deficiency"Trends Cardiovasc Med. 13. 136-141 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hirano K, et al.: "How a receptor for oxidized low deusity lipoprotein..."Proc 73rd Congress of EAS. (印刷中).

    • Related Report
      2003 Annual Research Report
  • [Publications] Kuwasako T, et al.: "Lipoprotein abnormalities in human CD36 deficiency…"Diabetes Care. (印刷中).

    • Related Report
      2002 Annual Research Report
  • [Publications] Hirano K, et al.: "Pathophysiology of human CD36 deficiency"Trends in Cardiovascular Med. (印刷中).

    • Related Report
      2002 Annual Research Report
  • [Publications] Hirano K, et al.: "How a receptor for oxidized low density lipoprotein…"Proc 33rd Congress of EAS. (印刷中).

    • Related Report
      2002 Annual Research Report
  • [Publications] Sugimoto T, et al.: "Decreased microsomal triglyceride transfer protein"J Hepats. 36. 157-162 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Miyaoka K, et al.: "CD36 deficiency associated with insulin iesistanie"Lancet. 357. 686-687 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hirano K, et al.: "Insulin resistance and CD36 deficiency"Lancet. 358. 244-244 (2001)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi